Kozminski University focuses on education based on reliable scientific knowledge, passed on in a modern way, by a properly prepared, experienced team of scientists, business practitioners and entrepreneurs. KU sees his development in the internationalization of the educational process, and international cooperation is one of the elements of the university's success.
The „WE! are Clinical Research" Movement was created with the intention of introducing international contribution to the discussion about clinical trials. In its assumptions, it wants to connect representatives of various environments, industries, and nationalities in order to exchange experiences and build wider cooperation and understanding of the goals of our activities. Therefore, on behalf of the Kozminski University and ours, we invite you to the next Webinar of the „WE! are Clinical Research” movement.
Project management in the clinical trials
Are changes to the methods of managing clinical trials possible? This time we will approach research in a more systemic and process-based manner, and the topic of the meeting will be Project Management in the Clinical Trials. The slogan Agile management is heard more and more, but is this "agile management" possible in the clinical research environment? In such large and complex environments and projects, are we able to apply a methodology that is mainly associated with the IT sector? During the meeting, we will get to know two different perspectives presented by Katarina Pavlović (SRB) and Raj Kumar (UK).
Time and place: April 15th, 2021 at 6:00 PM CET, online. The webinar will be conducted in Polish and English. Simultaneous translation will be available thanks to the support of the British Embassy in Poland. Technical issues will be communicated to those registered with a link to the event.
We act and support!
Every activity of the "WE! are the Clinical Research" will be associated with the support of the Kozminski Foundation, whose goals include activities for the development of science, education and upbringing and supporting gifted youth. The cost of participation in the Webinar is PLN 50 and the entire amount collected is allocated to the activities of the Kozminski Foundation.
See you at the webinar!
Katarina Pavlovic is assistant professor at the Faculty for project and innovation management in Belgrade, Serbia. She is a graduated biochemist with PhD in Quality management. She is especially attached to pharmaceutical sector as she started her career in a big pharmaceutical company in Serbia where she acquired knowledge and experience giving her the opportunity for advancement later on.
With over 20 years now of industrial experience and four years of experience in academia, she connects science with her expertise in business topics reaching targeted results.
Dr Pavlovic teaches introductory and upper-level courses in General Management, Contemporary Management, Project Management, Risks in Project Management, Knowledge and Innovation Management and Change Management with profound emphasis on fostering students’ commitment to learning and contribution to different aspects of business activities. Her major scientific research interests are in specificities of Agile transformation of businesses, application of methodologies of Knowledge and Innovation management, contribution of different aspects of leadership to overall business objectives and more.
She has thorough experience with strategy and business development along with innovation as a parameter for development and competitiveness. In consulting services, she addresses the issues of corporate growth, changing market conditions, capital requirements and investment options, risk mitigation, agile and business model transformation, learning and leadership. Her portfolio of consulting services includes 39 companies.
Dr. Raj Kumar is the Chief Medical officer and Founder of MeRaD Pharmaceuticals and co-founder of PharmaCambridge, Camnord and ArcezaPharma.
He is a graduate in Medicine and Surgery from the Universities of Dundee (M.B. ChB), and a graduate of University of London (BSc.) and obtained his post-graduate diploma in psychiatry and neurology from the Royal College of Surgeons in Ireland. (D.P.M)
Following a successful academic and clinical career, Raj joined SmithKline Beecham's Department of Human Pharmacology gaining experience in early phase drug development and experimental medicine including first in man studies. Subsequently, he joined the International Clinical Development Team as Director of Psychiatry and focused upon late-stage drug development, culminating in his role as VP and Director for US NeuroSciences and Gastroenterology, Clinical Development and Medical affairs. During this time, his team focused on the life-cycle management of Paxil resulting in its emergence as a billion-dollar product. Post-merger with Glaxo, Raj became VP and Global Head of Psychiatry. This included experience with biomarkers and surrogate markers, including EEG and MRI and psychometric batteries.
Raj has extensive experience of regulatory affairs, in Japan, India, Africa, Europe and North America, having successfully submitted a number of NDA’s, ANDA, CTA’s and IND as well face to face interaction with these agencies on scientific advice and both pre-IND and pre-NDA meetings.
On a move to Ranbaxy Laboratories, Raj served as President of R&D. Followed by President of Research and Development and Commercialization for NCE’s at Dr. Reddy’s Laboratories, Hyderabad India. Raj has extensive experience in drug development, regulatory affairs, project management, Quality Management Systems and commercial strategy in North America, Europe, Japan, and Asia.
Dr Kumar is a Fellow of the Royal Society of medicine and was a Fellow of the Institute of Directors UK. He was a visiting Professor at the University of Hyderabad. He has published extensively and has presented clinical and scientific research at both international and national forums He also served as a committee member for The Wellcome Trust for affordable health care fund for three years. Raj is a guest lecturer for the MBE/ MPhil course at the Institute of Biotechnology, University of Cambridge. Raj also serves as a Trustee for Multiple-Sclerosis- Shift UK, as well as a Governor at Cambridge Regional College.